Hindustan Unilever Ltd
NSE:HINDUNILVR
Hindustan Unilever Ltd
NSE:HINDUNILVR
Price:
2 338.9
INR
0.21%
Market Closed
Market Cap:
5.5T
INR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
HINDUNILVR Alert
Hindustan Unilever Ltd
2338.9
+5.0 (+0.21%)
| 52 Week Range |
2 194.05
3 028.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Hindustan Unilever Ltd
Balance Sheet
Balance Sheet Decomposition
Hindustan Unilever Ltd
Hindustan Unilever Ltd
| Current Assets | 213.2B |
| Cash & Short-Term Investments | 135.4B |
| Receivables | 30.4B |
| Other Current Assets | 47.5B |
| Non-Current Assets | 571.8B |
| Long-Term Investments | 8.3B |
| PP&E | 90.6B |
| Intangibles | 457.1B |
| Other Non-Current Assets | 15.8B |
| Current Liabilities | 128.8B |
| Accounts Payable | 104.9B |
| Short-Term Debt | 130m |
| Other Current Liabilities | 23.8B |
| Non-Current Liabilities | 144.1B |
| Long-Term Debt | 11.1B |
| Other Non-Current Liabilities | 133B |
Balance Sheet
Hindustan Unilever Ltd
Hindustan Unilever Ltd
Currency: INR
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
8 050
|
8 300
|
6 280
|
6 490
|
6 210
|
32 160
|
18 420
|
11 470
|
7 140
|
8 250
|
|
| Cash |
850
|
2 900
|
1 100
|
1 090
|
640
|
29 570
|
1 890
|
1 360
|
950
|
1 920
|
|
| Cash Equivalents |
7 200
|
5 400
|
5 180
|
5 400
|
5 570
|
2 590
|
16 530
|
10 110
|
6 190
|
6 330
|
|
| Short-Term Investments |
45 580
|
46 340
|
48 720
|
55 670
|
56 970
|
29 570
|
51 280
|
59 950
|
64 650
|
110 510
|
|
| Total Receivables |
15 350
|
17 850
|
17 400
|
25 640
|
26 750
|
27 740
|
30 800
|
35 660
|
38 650
|
35 600
|
|
| Accounts Receivables |
10 070
|
12 640
|
10 850
|
13 100
|
18 160
|
11 490
|
17 580
|
22 360
|
30 790
|
29 970
|
|
| Other Receivables |
5 280
|
5 210
|
6 550
|
12 540
|
8 590
|
16 250
|
13 220
|
13 300
|
7 860
|
5 630
|
|
| Inventory |
28 160
|
27 260
|
25 410
|
25 130
|
25 740
|
27 670
|
35 790
|
40 960
|
42 510
|
40 220
|
|
| Other Current Assets |
3 110
|
3 700
|
4 370
|
3 670
|
3 470
|
6 070
|
5 880
|
7 180
|
17 030
|
18 660
|
|
| Total Current Assets |
100 250
|
103 450
|
102 180
|
116 600
|
119 140
|
123 210
|
142 170
|
155 220
|
169 980
|
213 240
|
|
| PP&E Net |
31 870
|
35 730
|
41 970
|
45 410
|
45 980
|
55 570
|
68 610
|
74 820
|
80 810
|
90 560
|
|
| PP&E Gross |
0
|
35 730
|
41 970
|
45 410
|
45 980
|
55 570
|
68 610
|
74 820
|
80 810
|
90 560
|
|
| Accumulated Depreciation |
0
|
3 260
|
7 290
|
11 910
|
16 960
|
24 370
|
33 910
|
39 950
|
47 520
|
53 450
|
|
| Intangible Assets |
220
|
120
|
3 700
|
3 670
|
4 060
|
4 020
|
279 300
|
279 070
|
282 630
|
282 470
|
|
| Goodwill |
810
|
810
|
810
|
810
|
1 170
|
1 170
|
173 970
|
173 970
|
174 660
|
174 660
|
|
| Note Receivable |
5 240
|
5 500
|
6 570
|
9 020
|
12 070
|
14 670
|
17 150
|
15 700
|
14 720
|
15 680
|
|
| Long-Term Investments |
270
|
320
|
70
|
30
|
30
|
30
|
6 100
|
6 110
|
6 800
|
7 110
|
|
| Other Long-Term Assets |
1 650
|
2 010
|
1 760
|
3 080
|
3 840
|
2 860
|
270
|
280
|
1 270
|
1 270
|
|
| Other Assets |
810
|
810
|
810
|
810
|
1 170
|
1 170
|
173 970
|
173 970
|
174 660
|
174 660
|
|
| Total Assets |
140 310
N/A
|
147 940
+5%
|
157 060
+6%
|
178 620
+14%
|
186 290
+4%
|
201 530
+8%
|
687 570
+241%
|
705 170
+3%
|
730 870
+4%
|
784 990
+7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
54 410
|
56 850
|
61 860
|
71 700
|
72 060
|
75 350
|
88 020
|
90 680
|
95 740
|
104 860
|
|
| Accrued Liabilities |
2 910
|
2 030
|
2 110
|
2 390
|
2 060
|
2 160
|
0
|
2 820
|
2 870
|
4 370
|
|
| Short-Term Debt |
0
|
1 770
|
2 770
|
0
|
990
|
0
|
0
|
0
|
980
|
130
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2 360
|
2 780
|
3 020
|
3 140
|
3 650
|
|
| Other Current Liabilities |
9 240
|
10 020
|
10 400
|
14 780
|
11 560
|
13 300
|
20 230
|
16 280
|
17 550
|
15 750
|
|
| Total Current Liabilities |
66 560
|
70 670
|
77 140
|
88 870
|
86 670
|
93 170
|
111 030
|
112 800
|
120 280
|
128 760
|
|
| Long-Term Debt |
200
|
200
|
0
|
0
|
0
|
6 060
|
7 310
|
7 410
|
8 070
|
11 060
|
|
| Deferred Income Tax |
0
|
10
|
0
|
0
|
0
|
0
|
59 880
|
61 410
|
64 210
|
65 570
|
|
| Minority Interest |
190
|
200
|
220
|
200
|
180
|
170
|
200
|
260
|
2 180
|
2 050
|
|
| Other Liabilities |
8 820
|
11 130
|
12 260
|
16 740
|
20 770
|
19 840
|
32 410
|
32 680
|
33 090
|
65 370
|
|
| Total Liabilities |
75 770
N/A
|
82 210
+8%
|
89 620
+9%
|
105 810
+18%
|
107 620
+2%
|
119 240
+11%
|
210 830
+77%
|
214 560
+2%
|
227 830
+6%
|
272 810
+20%
|
|
| Equity | |||||||||||
| Common Stock |
2 160
|
2 160
|
2 160
|
2 160
|
2 160
|
2 160
|
2 350
|
2 350
|
2 350
|
2 350
|
|
| Retained Earnings |
61 140
|
62 380
|
64 450
|
69 510
|
75 310
|
78 810
|
70 630
|
84 540
|
97 260
|
106 310
|
|
| Additional Paid In Capital |
810
|
980
|
1 160
|
1 270
|
1 420
|
1 530
|
403 500
|
403 520
|
403 500
|
403 480
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
10
|
|
| Other Equity |
430
|
210
|
330
|
130
|
220
|
210
|
260
|
200
|
60
|
30
|
|
| Total Equity |
64 540
N/A
|
65 730
+2%
|
67 440
+3%
|
72 810
+8%
|
78 670
+8%
|
82 290
+5%
|
476 740
+479%
|
490 610
+3%
|
503 040
+3%
|
512 180
+2%
|
|
| Total Liabilities & Equity |
140 310
N/A
|
147 940
+5%
|
157 060
+6%
|
178 620
+14%
|
186 290
+4%
|
201 530
+8%
|
687 570
+241%
|
705 170
+3%
|
730 870
+4%
|
784 990
+7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2 163
|
2 164
|
2 164
|
2 165
|
2 165
|
2 165
|
2 350
|
2 350
|
2 350
|
2 350
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
